about
Charting a Path to Success in Virtual ScreeningModeling enzyme-ligand binding in drug discoveryExpanding the number of 'druggable' targets: non-enzymes and protein-protein interactionsSwissParam: A fast force field generation tool for small organic moleculesStructural genomics and drug discovery for infectious diseasesCrystallographic and Cellular Characterisation of Two Mechanisms Stabilising the Native Fold of α1-Antitrypsin: Implications for Disease and Drug DesignDocking for fragment inhibitors of AmpC -lactamaseFragment-based lead discovery: screening and optimizing fragments for thermolysin inhibitionFragment-Based Screen against HIV ProteaseFragment-Based Screening for Inhibitors of PDE4A Using Enthalpy Arrays and X-ray CrystallographyIdentification and Optimization of PDE10A Inhibitors Using Fragment-Based Screening by Nanocalorimetry and X-ray CrystallographySynthesis and structural characterisation of selective non-carbohydrate-based inhibitors of bacterial sialidasesWhy is Tanimoto index an appropriate choice for fingerprint-based similarity calculations?Atom-Atom-Path similarity and Sphere Exclusion clustering: tools for prioritizing fragment hitsHigh-performance drug discovery: computational screening by combining docking and molecular dynamics simulationsS-adenosyl-N-decyl-aminoethyl, a potent bisubstrate inhibitor of mycobacterium tuberculosis mycolic acid methyltransferasesBcL-xL conformational changes upon fragment binding revealed by NMRLigand pose and orientational sampling in molecular dockingKnowledge-based fragment binding predictionLigand Discovery for the Alanine-Serine-Cysteine Transporter (ASCT2, SLC1A5) from Homology Modeling and Virtual ScreeningFragment Screening of Human Aquaporin 1ZINC: a free tool to discover chemistry for biologyApplication of fragment-based drug discovery to membrane proteins: identification of ligands of the integral membrane enzyme DsbBFuture trends in screening technology for drug discovery.Docking Screens for Novel Ligands Conferring New Biology.Considerations for designing chemical screening strategies in plant biology.A big data approach to the ultra-fast prediction of DFT-calculated bond energiesFragment-based cocktail crystallography by the medical structural genomics of pathogenic protozoa consortium.Novel inhibitors of anthrax edema factor.Automated clustering of probe molecules from solvent mapping of protein surfaces: new algorithms applied to hot-spot mapping and structure-based drug design.Route to three-dimensional fragments using diversity-oriented synthesis.Screening of protein-protein interaction modulators via sulfo-click kinetic target-guided synthesisTargeting metalloproteins by fragment-based lead discovery.Design of a multi-purpose fragment screening library using molecular complexity and orthogonal diversity metrics.Visualisation of the chemical space of fragments, lead-like and drug-like molecules in PubChem.Identification of novel matrix metalloproteinase inhibitors by screening of phenol fragments library.Screening a fragment cocktail library using ultrafiltration.Screening the MayBridge Rule of 3 Fragment Library for Compounds That Interact with the Trypanosoma brucei myo-Inositol-3-Phosphate Synthase and/or Show Trypanocidal ActivityFragment-based screening by protein crystallography: successes and pitfalls.Higher throughput calorimetry: opportunities, approaches and challenges.
P2860
Q26779035-29C44CF1-DFE7-4CEB-83C4-4AAA7D71D293Q26784325-DADB0778-96A2-4DD6-9B56-2B4B2C65E0A7Q27003966-38F0A3FF-00B9-4DB8-96AF-4210E456D5A9Q27136894-97B2EECE-52CF-4A0D-88B2-8DF1F507B652Q27490495-17CF222E-CD59-458E-87F0-2C4BE0CB708EQ27653866-8CBFAC7F-E395-408F-A801-64656E38B830Q27655382-8A59AC63-455F-4E68-BDCB-2B3176F82E82Q27660547-9CF03E10-2B92-4531-9CDA-2ADCC51098EBQ27663595-C8F5C609-37D4-4DCB-A088-3A839AF0B63EQ27676592-C6AEF42C-2FE0-4C2C-B620-46FA50A3627AQ27681131-53D15B1A-8BF2-4A99-B257-771BDB876EDBQ27682822-2213B010-DFC8-4A71-B7F0-3DE0C06106CCQ27702310-85A8557F-A237-4D34-B796-1682D413D71EQ27902283-8AF03687-BB66-41F7-92BA-265C484C9A75Q28476233-3C1ADBB0-C79F-4D7B-B421-A6A7AEDE853FQ28486482-F1566D5E-52CA-4DD7-A6DD-CAC91BFBA8B1Q28533290-4C59ABF8-D020-4E04-BF7D-2F83BD854FC1Q28533958-CD850E1D-7E98-4169-B204-E8BF3332680BQ28538204-1C7347D6-11EC-45E7-8F6B-600C461C0891Q28550085-AC776698-300C-44E9-8865-FD49A4E2EA2BQ28833921-868888D9-B016-4B91-BCD7-4D05C7A37B27Q29615857-0A2794A7-0239-4875-96EF-F8018CB8706FQ30411815-5378AD7A-9C3B-400D-96CE-0BE07B63581EQ30428276-8213A91A-F951-4327-A739-9D295F9A3635Q30489011-4C1484B9-A3A0-410C-8BF3-863333FA770AQ30636976-25A894B7-D6AF-41F3-914E-96D42B095392Q30654902-549969B3-CF35-4255-9D84-11BC863078E9Q30904604-0B16E370-0DAD-48CE-AE99-F0AD301189C1Q33351165-EAC28951-1EBD-4164-99AD-5B2DB257FB92Q33797738-E7C1D76B-2F50-4F93-BC30-086AE3308AD8Q33868796-65AB9C39-2276-4B8E-AD36-D83387E0CEAEQ33877498-5479686B-CD01-4C58-8F38-76B6E1FBCA66Q33896509-97CC197B-8F4B-4F98-8A44-D8C4529351AFQ33908733-142F6534-7B43-4C1A-9B8C-C577ED7A512DQ33913583-D2D6DA9F-D365-492E-BE99-E00CC88FB81EQ33939916-1D4901FD-A1B9-4D53-9BAF-75E75A3F6A82Q33959477-68ADC20D-C52C-4EA8-B348-C3D9F7569E78Q34076392-5B9DECB0-B35C-4F45-9D35-E96F218D57D2Q34314898-F8154354-EB00-4BDD-804D-582861CB5842Q34338992-DCA03685-8A9F-4665-8429-6F98481F5E60
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Fragment-based lead discovery: leads by design
@ast
Fragment-based lead discovery: leads by design
@en
Fragment-based lead discovery: leads by design
@nl
type
label
Fragment-based lead discovery: leads by design
@ast
Fragment-based lead discovery: leads by design
@en
Fragment-based lead discovery: leads by design
@nl
prefLabel
Fragment-based lead discovery: leads by design
@ast
Fragment-based lead discovery: leads by design
@en
Fragment-based lead discovery: leads by design
@nl
P2093
P3181
P1433
P1476
Fragment-based lead discovery: leads by design
@en
P2093
Christopher W Murray
David C Rees
Miles Congreve
Robin A E Carr
P304
P3181
P356
10.1016/S1359-6446(05)03511-7
P407
P577
2005-07-15T00:00:00Z